SEC filing record
Primary Source · SEC.gov

JENOP GLOBAL HEALTHCARE FUND Ltd

Fund Vehicle2016 vintageRule 506(c), Section 3(c), Section 3(c)(7)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalSold increasedForm D/A · 2024-11-265 events: 2 investors increased, 1 sold increased, 1 large raiseLast filing 2024-11-26

Raised

$500M

Investors

128

Min Invest

$250,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

JENOP GLOBAL HEALTHCARE FUND Ltd is a Cayman Islands entity that first filed a Form D on October 30, 2014 and most recently amended it on February 17, 2026, describing itself as a hedge fund. The offering claims Rule 506(c), Section 3(c), Section 3(c)(7) and covers equity and pooled investment fund interests. JENOP GLOBAL HEALTHCARE FUND Ltd reported $500,371,688 sold from 128 investors in an offering of indefinite size as of the Form D filed February 17, 2026. The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $1,287 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is The Belvedere Building, 69 Pitts Bay Road, 2nd Floor, Pembroke, Bermuda HM08.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001562185
Entity NameJENOP GLOBAL HEALTHCARE FUND Ltd
ExemptionRule 506(c), Section 3(c), Section 3(c)(7)
What the exemption meansRule 506(c) of Regulation D: the issuer may advertise the offering publicly, but every purchaser must be a verified accredited investor. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(7) of the Investment Company Act: the fund is excluded from investment-company registration because every investor is a qualified purchaser, generally an individual with at least $5 million in investments or an institution with at least $25 million.
Entity TypeOther
Jurisdiction of OrganizationCayman Islands
Issuer AddressThe Belvedere Building, 69 Pitts Bay Road, 2nd Floor, Pembroke, Bermuda HM08
Phone(441) 292-8900
Industry / Fund TypePooled Investment Fund · Hedge Fund
Investment Company ActExcluded under Section 3(c)(7) (qualified purchasers only)
Securities TypeEquity, Pooled investment fund interests
First Sale DateNovember 1, 2012
Filing DateFebruary 17, 2026
Accession Number0001562185-26-000003
Total Offering AmountIndefinite
Total Amount Sold$500,371,688
Total Investors128
Non-Accredited InvestorsNone
Minimum Investment$250,000
Offering DurationIntended to last more than one year
Sales Commissions$1,287
Finders' Fees$0
Net Asset Value RangeDecline to Disclose
State (Issuer Address)D0
Amendment Count14 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest Nov 26, 2024

Critical / warning

0 / 1

2 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event Sold increase · Nov 26, 2024

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 5 filing events with values and deltas, latest 2024-11-26, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Adviser of Record (Form ADV)

Jennison Associates

CRD 107959 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a hedge fund

Auditor named on Form ADV: Deloitte & Touche LLP · PCAOB-registered per the adviser

From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Geoffrey Manfred Lewis

Director · New York, NY

Thomas Haskins Davis

Director · Hamilton, D0

Kenneth Haskins Moore

Director · New York, NY

Optima Managers Haskins LLC

Promoter · New York, NY

Neil Haskins Glass

Director · Hamilton, D0

Questions About JENOP GLOBAL HEALTHCARE FUND Ltd

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is JENOP GLOBAL HEALTHCARE FUND Ltd?

JENOP GLOBAL HEALTHCARE FUND Ltd is a Cayman Islands entity that filed a Form D with the SEC on February 17, 2026 as a hedge fund. The filing claims Rule 506(c), Section 3(c), Section 3(c)(7) for an offering of equity and pooled investment fund interests.

Is JENOP GLOBAL HEALTHCARE FUND Ltd legit?

AltStreet does not rate legitimacy; it reports the public record. JENOP GLOBAL HEALTHCARE FUND Ltd filed a Form D with the SEC on February 17, 2026 claiming Rule 506(c), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $500,371,688 sold to 128 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is JENOP GLOBAL HEALTHCARE FUND Ltd registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that JENOP GLOBAL HEALTHCARE FUND Ltd claimed Rule 506(c), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has JENOP GLOBAL HEALTHCARE FUND Ltd raised?

JENOP GLOBAL HEALTHCARE FUND Ltd reported $500,371,688 sold from 128 investors in an offering of indefinite size as of the Form D filed February 17, 2026.

Who can invest in JENOP GLOBAL HEALTHCARE FUND Ltd?

The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.

What is the minimum investment in JENOP GLOBAL HEALTHCARE FUND Ltd?

The Form D lists $250,000 as the minimum investment accepted from any outside investor as of February 17, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling JENOP GLOBAL HEALTHCARE FUND Ltd and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $1,287 and finders' fees as $0. Form D allows these to be estimates.

Who is behind JENOP GLOBAL HEALTHCARE FUND Ltd?

The Form D lists 5 related persons: Geoffrey Manfred Lewis, director; Thomas Haskins Davis, director; Kenneth Haskins Moore, director; Optima Managers Haskins LLC, promoter; Neil Haskins Glass, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is JENOP GLOBAL HEALTHCARE FUND Ltd located?

The issuer's address on its SEC filings is The Belvedere Building, 69 Pitts Bay Road, 2nd Floor, Pembroke, Bermuda HM08. Its phone number of record is 4412928900. It is organized under the laws of Cayman Islands.

How long is the JENOP GLOBAL HEALTHCARE FUND Ltd offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 14 amendments are on record for this CIK.

How large is JENOP GLOBAL HEALTHCARE FUND Ltd?

The issuer declined to disclose its net asset value range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.